Assignee profile:

Rottapharm S.p.A.

City:

Milano

Country:

Italy

Published Applications:

22

Last publication date:

2014-08-28

Patent Grants:

14

Last grant date:

2015-09-01

Top Inventors for applications by Rottapharm S.p.A.

These are the the leading inventors for applications assigned to Rottapharm S.p.A.:

Recent patent applications by Rottapharm S.p.A.

Rottapharm S.p.A. based in Milano, IT has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-08-28 ✅ Patent 9,120,824 granted on 2015-09-01
US20140243373A1
Chemistry; metallurgy

Cyclic amine derivatives as EPreceptor agonists

#2 | 2013-11-21
US20130310400A1
Chemistry; metallurgy

SPIRO AMINIC COMPOUNDS WITH NK1 ANTAGONIST ACTIVITY

#3 | 2013-06-27 ✅ Patent 9,162,979 granted on 2015-10-20
US20130165494A1
Chemistry; metallurgy

1,5-Diary1-2-alkylpyrrole-3-substituted nitro esters, selective COX-2 inhibitors and nitric oxide donors

#4 | 2012-11-15 ✅ Patent 9,062,129 granted on 2015-06-23
US20120289478A1
Chemistry; metallurgy

Hyaluronic acid esters, their preparation and use in dermatology

#5 | 2011-11-24 ✅ Patent 8,258,185 granted on 2012-09-04
US20110288173A1
Human necessities

Use of neboglamine in the treatment of toxicodependency

#6 | 2011-10-20 ✅ Patent 8,193,353 granted on 2012-06-05
US20110257209A1
Chemistry; metallurgy

6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents

#7 | 2011-05-19 ✅ Patent 8,633,208 granted on 2014-01-21
US20110118289A1
Human necessities

6-1H-imidazo-quinazoline and quinolines derivatives, new MAO inhibitors and imidazoline receptor ligands

#8 | 2011-04-14
US20110086896A1
Chemistry; metallurgy

Crystalline and Stable Form of Andolast

#9 | 2011-03-17
US20110065797A1
Human necessities

DELOXIGLUMIDE AND PROTON PUMP INHIBITORS COMBINATION IN THE TREATMENT OF GASTROINTESTINAL DISORDERS

#10 | 2011-02-24
US20110045033A1
Human necessities

Combination of Itriglumide and Proton Pump Inhibitors in the Treatment of Gastrointestinal and Related Disorders

#11 | 2011-01-06 ✅ Patent 8,372,866 granted on 2013-02-12
US20110003861A1
Chemistry; metallurgy

2-aryl and 2-heteroaryl 4H-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents for the treatment of arthritis, cancer and related pain

#12 | 2010-08-05
US20100197962A1
Human necessities

Use of Neboglamine in the Treatment of Toxicodependency

#13 | 2010-02-04
US20100028395A1
Human necessities

COMPOSITIONS CONTAINING N-ACETYLGLUCOSAMINE FOR USE IN DERMO-COSMETOLOGY AND AESTHETIC MEDICINE

#14 | 2009-10-22 ✅ Patent 7,994,181 granted on 2011-08-09
US20090264451A1
Chemistry; metallurgy

6-1H-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents

#15 | 2009-09-10 ✅ Patent 7,968,558 granted on 2011-06-28
US20090227609A1
Chemistry; metallurgy

Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents

#16 | 2009-05-28 ✅ Patent 9,623,108 granted on 2017-04-18
US20090136469A1
Human necessities

Formulation for oral administration with beneficial effects on the cardiovascular system

#17 | 2008-08-14
US20080194877A1
Human necessities

Benzamidine Derivatives for Treatment and Prevention of Cancer Therapy Induced Mucositis

#18 | 2008-05-01
US20080102082A1
Human necessities

Formulation for Oral Administration Having a Health-Promoting Effect on the Cardiovascular System

#19 | 2008-01-03 ✅ Patent 7,846,921 granted on 2010-12-07
US20080004303A1
Human necessities

Method of relieving symptoms of gastroesophageal reflux disease

#20 | 2007-12-20 ✅ Patent 7,863,330 granted on 2011-01-04
US20070293574A1
Human necessities

Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders

#21 | 2007-06-28 ✅ Patent 7,824,710 granted on 2010-11-02
US20070149586A1
Chemistry; metallurgy

Crystalline and stable form of andolast

#22 | 2006-05-25 ✅ Patent 7,294,648 granted on 2007-11-13
US20060111304A1
Chemistry; metallurgy

Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof

AssigneeID:

28184 ⎘